Roxanne Oulman - Oct 15, 2021 Form 4 Insider Report for Medallia, Inc. (MDLA)

Role
CFO and EVP
Signature
/s/ Katheryn Delor, by power of attorney
Stock symbol
MDLA
Transactions as of
Oct 15, 2021
Transactions value $
-$1,331,662
Form type
4
Date filed
10/18/2021, 07:05 PM
Previous filing
Sep 16, 2021
Next filing
Nov 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDLA Common Stock Options Exercise $67.3K +10K +2.26% $6.73* 453K Oct 15, 2021 Direct
transaction MDLA Common Stock Sale -$1.28M -37.7K -8.33% $33.95 415K Oct 15, 2021 Direct F1, F2
transaction MDLA Common Stock Sale -$119K -3.52K -0.85% $33.96 411K Oct 18, 2021 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDLA Employee Stock Option (right to buy) Options Exercise $0 -10K -1.2% $0.00 825K Oct 15, 2021 Common Stock 10K $6.73 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Of the reported shares, 12,070 were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs, and the remaining shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.95 to $33.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4).
F3 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2021.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.95 to $33.97, inclusive.
F5 One-fourth of the shares subject to the option vested on November 5, 2019 and 1/48th vest monthly thereafter.